相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
99
- 英文名:
Biotinylated Recombinant SARS-CoV-2 S Protein RBD (carrier-free)
- 供应商:
北京云肽生物科技有限公司
美国 BioLegend 公司位于美国加州,致力于为生物医药研究的各个前沿领域提供高质量的抗体及其它相关试剂。BioLegend 虽然成立的时间不长,但它聚集了一批来自 PharMingen 公司的专业人士,建立了一支具有雄厚技术背景的专业队伍。通过其自身的先天优势,以及与世界知名实验室和研究所的良好合作关系,以合理的价格为广大客户提供高质量的免疫学和细胞生物学产品。
BioLegend 公司以其专业技术力量为保证,提供各种质量卓越的产品,并不断地开发新产品,以满足飞速发展的生命科学研究的需要。
BioLegend 793906 Biotinylated Recombinant SARS-CoV-2 S Protein RBD (carrier-free)
产品简介:
产品品牌:BioLegend
产品货号:793906
产品名称:BioLegend 793906 Biotinylated Recombinant SARS-CoV-2 S Protein RBD (carrier-free)
产品规格:100 µg
产品说明:
Regulatory Status RUO
Other Names S1 RBD, Spike Protein RBD
描述
SARS-CoV-2是一种导致2019guan状病毒病(新冠肺炎)的呼吸道病毒。冠状病毒刺突(S)糖蛋白是病毒粒子外壳上的一种I类病毒融合蛋白,通过识别宿主细胞受体并介导病毒和细胞膜的融合,在病毒感染中发挥关键作用。S糖蛋白是由约1300个氨基酸组成的前体蛋白,然后被切割成氨基(N)末端S1亚基(约700个氨基酸)和羧基(C)末端S2亚基(600个氨基酸)。三个S1/S2异二聚体组装形成从病毒包膜突出的三聚体刺突。S1亚基包含一个受体结合结构域(RBD),该结构域可以特异性结合靶细胞上的受体血管紧张素转化酶2(ACE2)。通过受体结合、蛋白水解处理和/或细胞区室中的酸性pH触发,I类病毒融合蛋白在感染期间经历从亚稳定的融合前状态到稳定的融合后状态的转变,其中受体结合亚基被切割,融合亚基进行大规模构象重排,暴露疏水性融合肽,诱导形成六螺旋束,使病毒和细胞膜接近融合。由三个S1-S2异二聚体组成的三聚体SARS guan状病毒(SARS-CoV-2)S糖蛋白结合细胞受体血管紧张素转化酶2(ACE2),并通过融合前到融合后的构象转变介导病毒和细胞膜的融合。
SARS-CoV-2 is a respiratory virus which causes coronavirus disease 2019 (COVID-19). The coronavirus spike (S) glycoprotein is a class I viral fusion protein on the outer envelope of the virion that plays a critical role in viral infection by recognizing host cell receptors and mediating fusion of the viral and cellular membranes. The S glycoprotein is synthesized as a precursor protein consisting of ~1,300 amino acids that is then cleaved into an amino (N)-terminal S1 subunit (~700 amino acids) and a carboxyl (C)-terminal S2 subunit (~600 amino acids). Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. Triggered by receptor binding, proteolytic processing and/or acidic pH in the cellular compartments, the class I viral fusion protein undergoes a transition from a metastable pre-fusion state to a stable post-fusion state during infection, in which the receptor-binding subunit is cleaved, and the fusion subunit undergoes large-scale conformational rearrangements to expose the hydrophobic fusion peptide, induce the formation of a six-helix bundle, and bring the viral and cellular membranes close for fusion. The trimeric SARS coronavirus (SARS-CoV-2) S glycoprotein consisting of three S1-S2 heterodimers binds the cellular receptor angiotensin-converting enzyme 2 (ACE2) and mediates fusion of the viral and cellular membranes through a pre- to post-fusion conformation transition.
Product Details
Source
SARS-CoV-2 S Protein RBD, amino acid Arg319-Phe541 (Accession # QHD43416.1), with a C-terminal 8-his tag and an Avi-tag was expressed in 293E cells. SARS-CoV-2 S Protein RBD was site-specifically biotinylated by enzyme BirA.
Molecular Mass
The 260 amino acid recombinant protein has a predicted molecular mass of approximately 28.9 kD. The DTT-reduced and non-reduced proteins migrate at approximately 35 kD and 30 kD by SDS-PAGE, respectively. The predicted N-terminal amino acid is Arg.
Purity
> 95%, as determined by Coomassie stained SDS-PAGE
Formulation
0.22 µm filtered protein solution is in PBS, pH 7.2.
Endotoxin Level
Less than 0.1 EU per µg protein as determined by the LAL method
Concentration
10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & Handling
Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
Activity
When recombinant ACE2-Fc chimera (Cat. No. 793202) is immobilized at 1 µg/mL, biotinylated recombinant SARS-CoV-2 S Protein RBD binds in a dose-dependent manner. The EC50 range for this effect is 8 - 40 ng/mL. HRP Avidin (Cat. No. 405103) was used to detect the binding.
Application Bioassay
Antigen Details
Structure Biotinylated
Distribution SARS-CoV-2
Function
Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection
Interaction Lung cells
Ligand/Receptor ACE2
Bioactivity
Measured by its ability to bind recombinant human ACE2
Biology Area COVID-19
以下是 BioLegend 品牌部分产品,如需其他产品请联系本公司销售。
BioLegend 100410 PE/Cyanine5 anti-mouse CD4 GK1.5 100 ug
BioLegend 100412 APC anti-mouse CD4 GK1.5 100 ug
BioLegend 100421 PE/Cyanine7 anti-mouse CD4 GK1.5 25 ug
BioLegend 100422 PE/Cyanine7 anti-mouse CD4 GK1.5 100 ug
BioLegend 100423 Alexa Fluor® 488 anti-mouse CD4 GK1.5 100 ug
BioLegend 100424 Alexa Fluor® 647 anti-mouse CD4 GK1.5 100 ug
BioLegend 100428 Pacific Blue™ anti-mouse CD4 GK1.5 100 ug
BioLegend 100429 Alexa Fluor® 700 anti-mouse CD4 GK1.5 25 ug
BioLegend 100430 Alexa Fluor® 700 anti-mouse CD4 GK1.5 100 ug
BioLegend 100431 PerCP anti-mouse CD4 GK1.5 25 ug
BioLegend 100433 PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 25 ug
BioLegend 100434 PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 100 ug
BioLegend 100437 Brilliant Violet 421™ anti-mouse CD4 GK1.5 125 uL
BioLegend 100438 Brilliant Violet 421™ anti-mouse CD4 GK1.5 500 uL
BioLegend 100442 Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 1 mg
BioLegend 100443 Brilliant Violet 421™ anti-mouse CD4 GK1.5 50 ug
BioLegend 100446 Alexa Fluor® 594 anti-mouse CD4 GK1.5 100 ug
BioLegend 100449 Brilliant Violet 510™ anti-mouse CD4 GK1.5 50 ug
BioLegend 100451 Brilliant Violet 605™ anti-mouse CD4 GK1.5 50 ug
BioLegend 100455 PE/Dazzle™ 594 anti-mouse CD4 GK1.5 25 ug
BioLegend 100456 PE/Dazzle™ 594 anti-mouse CD4 GK1.5 100 ug
BioLegend 100458 Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 25 mg 
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验-Buffer® or LowCross-Buffer® STRONG as sample diluent, PlateBlock™ shows very good performance in serological ELISA tests, such as assays for neutralizing SARS-CoV-2 antibodies (s. also Fig. 5). The many benefits of animal-free solutions Animal
BioID: A Screen for Protein‐Protein Interactions
expressing cells. (4 ) Induce biotinylation with excess biotin prior to (5 ) cell lysis and protein denaturation. (6 ) Perform biotin‐affinity capture of biotinylated proteins. (7 ) Reserve 10% of the sample for streptavidin immunoblot analysis. Use
1) Handling Instructions for standards are lot-specific. Refer to product information for proper handling. 2) Recombinant protein vials should be quick-spun for maximum recovery. 3) BioLegend suggests that cytokines be stored
技术资料暂无技术资料 索取技术资料










